4//SEC Filing
Bass James Edward 4
Accession 0001209191-19-036719
CIK 0001358762other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:04 PM ET
Size
8.0 KB
Accession
0001209191-19-036719
Insider Transaction Report
Form 4
Bass James Edward
Director
Transactions
- Award
Stock Option (right to buy)
2019-06-12+9,000→ 9,000 totalExercise: $88.75Exp: 2029-06-12→ Class B common stock (9,000 underlying) - Award
Stock Option (right to buy)
2019-06-12$57.59/sh+1,065$61,333→ 1,065 totalExercise: $88.75Exp: 2029-06-12→ Class B common stock (1,065 underlying)
Footnotes (3)
- [F1]The options vest in 4 equal installments on September 12, 2019, December 12, 2019, March 12, 2020, and June 12, 2020, subject to continued service through each vesting date.
- [F2]The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.
- [F3]This option was issued to the reporting person pursuant to the Reata Non-Employee Director Compensation Policy in lieu of future director fees of $61,375.
Documents
Issuer
REATA PHARMACEUTICALS INC
CIK 0001358762
Entity typeother
Related Parties
1- filerCIK 0001662321
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 4:04 PM ET
- Size
- 8.0 KB